latest news releases from the newsroom
DirectView Secures $1,000,000 Financing
BOCA RATON, Fla., April 13, 2005 (PRIMEZONE) -- DirectView, Inc. (OTCBB:DRVW) has announced that they have entered into a definitive agreement with Highgate House, a private equity fund, to sell $1,000,000.00 of the Company's 7% Secured Convertible Debentures due April 1, 2006. The Debentures are convertible into DirectView common stock at a fixed floor price of no less than $.024 per share. The Company will receive the funds in two tranches, the first $500,000 has just been received and the second $500,000 will be received upon the filing of a registration statement to register the common stock underlying the Debentures which are due April 1, 2006.
StarMed Group Inc.
StarMed Shares Cleared For Trading
LOS ANGELES, April 13, 2005 (PRIMEZONE) -- StarMed Groups Inc. (OTCBB: SMEG), was cleared by the N.A.S.D. effective March 17, 2005 for trading. StarMed Group, originally formed in 1962, is a company that recently changed its focus to acquire and develop various projects in the emerging wellness industry. In 1999, StarMed acquired Sierra Medicinals Inc., a medical company uniquely focused on integrated medicine for the prevention of disease as well as its treatment. Sierra is also unique in that it relies on its physicians to review and approve all products prior to making them available to the consumer.
Dow Jones Indexes
STOXX Ltd. Launches First Pan-European Select Dividend Indexes
ZURICH, Switzerland, April 13, 2005 (PRIMEZONE) -- STOXX Ltd., the leading European index provider, today launched the first pan-European select dividend indexes. The Dow Jones STOXX Select Dividend 30 Index -- covering Europe -- and the Dow Jones EURO STOXX Select Dividend 30 Index -- covering the Eurozone -- track the 30 highest dividend-paying stocks relative to their respective home markets.
Observer Appeals Against Decision on Raised Tax Assessment
STOCKHOLM, Sweden, April 13, 2005 (PRIMEZONE) -- The Swedish tax authorities have decided to raise Observer AB's taxable income for year 2000 with approximately SEK 440 million, which would result in tax costs of SEK 173 million. The decision concerns the sale of Sifo Research & Consulting.
Xenova Group PLC
Xenova Grants Licence to PharmaEngine
SLOUGH, U.K., April 13, 2005 (PRIMEZONE) -- Xenova Group plc (Nasdaq:XNVA) (LSE:XEN) today announced that it has entered into a licensing agreement for its lead product candidate, TransMID(TM), with PharmaEngine, Inc. (PEI) of Taiwan for the Chinese and South Korean markets.Under the terms of the agreement, Xenova will receive an upfront payment as well as milestone payments and significant royalties on potential future sales. Xenova also retains manufacturing rights and will be the exclusive supplier of TransMID(TM) to PEI. PEI receives exclusive rights to develop, market and sell TransMID(TM) in both the People's Republic of China and in the Republic of South Korea following PEI sponsored registration trials in these countries.
Tele2 Notice of Annual General Meeting
STOCKHOLM, Sweden, April 13, 2005 (PRIMEZONE) -- The Shareholders in Tele2 AB (publ) are hereby invited to the Annual General Meeting on Wednesday 11 May 2005 at 1:30 p.m. CET at the cinema Skandia, Drottninggatan 82 in Stockholm.